Latest Breaking News On - Simcere pharmaceutical group - Page 4 : comparemela.com

Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart

On November 21, 2023, Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an innovative IL-4Rα monoclonal antibody.

Jinsheng renDuplizumab dupixentSimcere pharmaceutical groupDrug administrationGreater chinaPharmaceutical groupConnect biopharma hongkong limitedInflammatory diseasesClinical trialGreater chinaSimcere pharmaceutical group limitedSynergistic effectCommercialization effortsMonoclonal antibody

Simcere Pharma, Connect Biopharma Enter Into Agreement For Autoimmune Drug Rademikibart

Simcere Pharma, Connect Biopharma Enter Into Agreement For Autoimmune Drug Rademikibart
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterSimcere pharmaceutical groupBiopharma hongkongPharmaceutical group limitedConnect biopharma hongkong limitedGreater chinaLassen sie

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Zheng weiHong kongJinsheng renTim mccarthySimcere pharmaceutical groupCompany annual report on formBiopharma holdings limited nasdaqOncology drug developmentCompany greater chinaSuzhou connect biopharma co ltdSimcere pharmaceutical group ltdKey laboratory of neurologyExchange commissionSimcere pharmaceutical co ltdBiopharma hong kongBiopharma holdings

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zheng weiHong kongJinsheng renBiopharma hong kongSimcere pharmaceutical co ltdBiopharma holdings limited nasdaqSimcere pharmaceutical group ltdSuzhou connect biopharma co ltdConnect biopharma holdings limitedConnect biopharma hong kong limitedSimcere pharmaceutical groupConnect biopharmaGreater china

Simcere Pharmaceutical Group Limited Enters into an Exclusive License and Collaboration Agreement with Connect Biopharma Hongkong Limited in Relation to Rademikibart

The board of directors of Simcere Pharmaceutical Group Limited announced that, on November 21, 2023, the Group entered into an exclusive license and collaboration agreement with Connect Biopharma.

Simcere pharmaceutical groupSimcere pharmaceutical group limitedConnect biopharma hongkong limitedGreater chinaConnect biopharma